
Feb 25 (Reuters) - Tandem Diabetes Care Inc TNDM.O:
TANDEM DIABETES CARE ANNOUNCES FDA CLEARANCE OF CONTROL-IQ+ AUTOMATED INSULIN DELIVERY TECHNOLOGY FOR PEOPLE WITH TYPE 2 DIABETES
TANDEM DIABETES CARE INC: CONTROL-IQ+ IS EXPECTED TO BE AVAILABLE FOR NEW AND EXISTING CUSTOMERS IN UNITED STATES IN MARCH 2025
Source text: ID:nBw934rdga
Further company coverage: TNDM.O